Stocktoria
AMARIN CORP PLCUK AMRN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1993-04-01
AMARIN CORP PLCUK statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 56.6% | 35.6% | 53.9% | 65.7% | 79.2% |
| Operating margin | -23.5% | -40.2% | -22.0% | -28.7% | 1.8% |
| Net margin | -18.2% | -35.9% | -19.3% | -28.7% | 1.3% |
| Return on assets | -5.8% | -12.0% | -7.1% | -11.9% | 0.7% |
| Return on equity | -8.4% | -16.9% | -10.7% | -17.8% | 1.2% |
| Current ratio | 3.34 | 3.31 | 2.80 | 2.66 | 2.37 |
| Revenue growth | -6.5% | -25.5% | -16.9% | -36.7% | -5.0% |
Source: SEC EDGAR filings · CIK 0000897448 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.